摘要
目的探讨乌司他丁联合奥曲肽治疗急性胰腺炎的临床效果.方法此次报告时间区间为2019年6月-2022年11月,选取的125例调查对象均是宜兴市和桥医院收治的急性胰腺炎患者,随机将其分为常规组和研究组,两组均接受基础治疗,常规组63人采用奥曲肽治疗,研究组62人以乌司他丁联合奥曲肽为治疗方案,分析治疗效果.结果研究组治疗有效率为96.77%,比常规组(84.13%)更高,P<0.05;研究组腹胀消失时间、腹部压痛消失时间、首次排便时间、住院时间、肠鸣音恢复时间均更短,P<0.05;研究组的不良反应几率为4.84%,常规组不良反应几率为7.94%,二者对比无统计学意义(P>0.05).结论乌司他丁联合奥曲肽治疗急性胰腺炎疾病的效果显著,可缩短住院时间,且不良反应发生几率较低,值得推广.
Objective To explore the clinical efficacy of ulinastatin combined with octreotide in the treatment of acute pancreatitis.Method The time interval of this report was from June 2019 to November 2022.125 survey subjects were all acute pancreatitis patients admitted to our hospital.They were randomly divided into a conventional group and a research group using a digital randomization table.Both groups received basic treatment,and 63 people in the conventional group joined octreotide treatment,The research group of 62 people used ulinastatin combined with octreotide as the treatment plan to analyze the treatment effect.Result The treatment efficiency of the research group was 96.77%,which was higher than that of the conventional group(84.13%),P<0.05;the disappearance time of abdominal distension,abdominal tenderness,first defecation time,hospitalization time,and recovery time of bowel sounds were shorter in the study group(P<0.05);the incidence of adverse reactions in the study group was 4.84%,while the incidence of adverse reactions in the conventional group was 7.94%.There was no statistically significant difference between the two groups(P>0.05).Conclusion The combination of ulinastatin and octreotide has a significant effect on the treatment of acute pancreatitis,shortens hospitalization time,and has a low probability of adverse reactions,which is worth promoting.
作者
冯亮
Feng Liang(Department of Gastroenterology,Yixing City Jianqiao Hospital,Yixing,Jiangsu 214211,China)
出处
《首都食品与医药》
2023年第17期73-75,共3页
Capital Food Medicine
关键词
急性胰腺炎
乌司他丁
奥曲肽
治疗效果
acute pancreatitis
Ulinastatin
Octreotide
treatment effect
